Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase Inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50% between 2015 and 2020.
Depression is a medical disorder that mainly involves the brain. An individual with depression feel sad, tired, lack energy, and have intricacy enjoying routine activities every day. It is a very common condition that affects about 1 in every 5 individual in the U.S. Many factors can cause depression, including genes, factors such as stress and brain chemistry. According to WHO (world health organization and center for disease control) at present, an estimated 350 million people worldwide are affected by depression.
Request For Free Sample Report: http://www.marketresearchstore.com/report/depression-drug-market-z53043#RequestSample
Some of the key reasons driving depression drug market are growing geriatric population, rising efficacy and declining side effects of drugs in numerous classes. Nevertheless, present circumstances specify that the overall depression drug market would decline owing to patent expiry of main antidepressants, rising number of generic drug variants and the weak pipeline of new drugs.
Different types of depression also have dissimilar symptoms. Several types of depression disorders include postpartum depression, major or clinical depressive disorder, dysthymic disorder, psychotic depression and seasonal affective disorder. Different classes of depression drugs are anticonvulsants, serotonin-norepinephrine reuptake inhibitors, beta-blockers, benzodiazepines, tetracyclic antidepressants (TeCAs), selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs) among others. Among all classes, SNRIs emerged as a budding segment in 2014 and held more than 32% of the overall market share. However, it is predicted that this segment may exhibit a decline in growth in the near future.
Know more before buying this report: http://www.marketresearchstore.com/report/depression-drug-market-z53043#InquiryForBuying
Geographically, North America emerged as the major regional market for the global depression drug in 2014. This dominance was mainly because of the presence of large population infected with numerous kinds of depression and anxiety disorders. Currently, U.S. is saturated as a variety of antidepressant drugs are available on prescription for the similar symptom. Depression drug market growth heavily relies on the introduction of more efficient drugs for latest symptoms. Asia Pacific is predicted to show moderate growth due to the presence of emerging economies such as Japan, Australia, and China. Growth in this region is attributed to different factors such as positive marketing approval for novel medicines, the presence of a large population base in the region and increasing geriatric population.
Browse the full report at: http://www.marketresearchstore.com/report/depression-drug-market-z53043
Major companies operating in this field are H. Lundbeck, Opko Health, Gedeon Richter, Intra-Cellular Therapies, Janssen Pharmaceuticals, Lupin, Luye Pharma, MSI Methylation Sciences, Naurex, Abbott Laboratories, Novartis, Otsuka Pharmaceutical and SK Biopharmaceuticals among others.
This report segments the global depression drug market as follows:
Class Segment Analysis: Atypical Antipsychotics, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Tetracyclic Antidepressants, Monoamine Oxidase inhibitors, Benzodiazepines, Others
Regional Segment Analysis: North America (US), Europe(Germany, France, UK), Asia Pacific(China, Japan, India), Latin America(Brazil), Middle East and Africa
Visit Our Blog: https://marketresearchstore2017.wordpress.com
About Us: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal Industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
3422 SW 15 Street, Suit #8138
Deerfield Beach, Florida 33442
Toll Free: +1-855-465-4651 (USA-CANADA)